A GSR Ventures survey of 50 investors reveals return on investment and clinical validation would be vital to a company’s success next year.
Survey: Digital health investments will rely on ROI and clinical validation in 2023
A GSR Ventures survey of 50 investors reveals return on investment and clinical validation would be vital to a company’s success next year.
